← Back to Clinical Trials
Recruiting NCT06271447

NCT06271447 Answerability and Minimal Clinical Significance of the Pain Questionnaires

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06271447
Status Recruiting
Phase
Sponsor Acibadem University
Condition Chronic Low-back Pain
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2024-03-04
Primary Completion 2024-12

Trial Parameters

Condition Chronic Low-back Pain
Sponsor Acibadem University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-03-04
Completion 2024-12
Interventions
Traditional therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To investigate the reliability and sensitivity of the Turkish versions of the Fear-Avoidance Beliefs Questionnaire, Tampa Scale for Kinesiophobia, and The Pain Catastrophizing Scale in patients with chronic non-specific low back pain undergoing multidisciplinary rehabilitation.

Eligibility Criteria

Inclusion Criteria: * Getting diagnosed with chronic non-specific low back pain * Being able to read and speak Turkish * Being between the ages of 18 and 65 * Agreeing to participate in the research and signing the voluntary consent form. Exclusion Criteria: * Presence of systemic disease * Cognitive impairment status (Mini-Mental State Examination \<24), * Recent (\<12 weeks) history of myocardial infarction, cerebrovascular accident * Presence of radiculopathy, infection, tumor, osteoporosis, vertebral fracture, trauma and surgery in the lumbar region * Having previously received any exercise therapy and/or training in pain neuroscience. * Refusal of treatment or failure to comply with treatment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology